logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Repros Jumps on Positive Drug Trials

By  +Follow September 17, 2013 8:01AM
Share:
Tickers Mentioned:

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on. The spike, driven by positive topline results from the most recent study on its drug Androxal® reported after close on Monday, pushed Repros stock to a new 52-week high.

Positive results for Androxal

Androxal is being developed for men of reproductive age with low testosterone due to secondary hypogonadism, which is also associated with obesity and could be among the most common causes of low testosterone. Repros reported that Andorxal met both co-primary endpoints in its second pivotal study, with 81 percent of subjects using the drug experiencing normalized testosterone and no 24-hour average testosterone levels outside of normal ranges. Androxal, which is in a class similar to Sanofi’s (SNY) Clomid®, could receive a strong share of the testosterone replacement therapy (TRT) market because it could also help preserve male fertility while being administered orally, making it significantly more convenient than testosterone replacement injections.  

Possible Sale

Brean Capital initiated coverage of Repros in July of this year, calling it a buy and setting a price target of $32. At the time, analyst Jonathan Aschoff said “Its lead compound Androxal is being evaluated in a Phase 3 program for secondary hypogonadism with results in 4Q13 and 2Q14, which in our view would be key investment catalysts, and we project Androxal launch in mid-2015.” Now, Brean is citing these positive results as a reason for optimism, as well as reports that management may have interest in selling the company. Brean estimated the sell-price potentially reaching $40 a share, in the event that the sale goes down.

In addition to Andorxal, Repros currently has female reproductive drug Proellex® in the pipeline, intended for use in uterine fibroids and endometriosis. “The vaginal formulation of Proellex (Proellex-V) will enter Phase 2b in 2H13 for uterine fibroids with an NDA submission expected in 2016. All compounds are protected by U.S. patents," said Aschoff in July.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for RPRX
Penny Stockington
4 Jul 15 22:55:50
$SUTI Has Gained 66.67%, Since Our Penny Stock Blog Alert! Huge News: http://t.co/llIxl7uvGj $ANAC $ACTV $RPRX
Stock Dawgzz
4 Jul 15 22:49:48
Our Platinum Subscribers Saw Their Penny Stock Alerts Gain Over 200% In 2 Weeks! Big Update: http://t.co/Lhta1yqlzk $ANAC $ACTV $RPRX
Stockaholics
4 Jul 15 22:49:20
$SUTI Has Now Seen 400% Gains In The Past 2 Weeks! Special Update: http://t.co/l1zbyeF3OQ $ANAC $ACTV $RPRX
Stock Rocket
4 Jul 15 22:47:38
Our Penny Stock Newsletter Alerts Gained 200% In 2 Weeks! Get Our Next Pick Early: http://t.co/4eX1MHBloV $ANAC $ACTV $RPRX
Penny Stockington
4 Jul 15 20:00:23
$SUTI Has Gained 66.67%, Since Our Penny Stock Blog Alert! Huge News: http://t.co/llIxl7cUOL $ANAC $ACTV $RPRX
Stockaholics
4 Jul 15 19:49:23
$SUTI Has Now Seen 400% Gains In The Past 2 Weeks! Special Update: http://t.co/l1zbyeWEGo $ANAC $ACTV $RPRX
Stock Dawgzz
4 Jul 15 19:48:07
Our Platinum Subscribers Saw Their Penny Stock Alerts Gain Over 200% In 2 Weeks! Big Update: http://t.co/Lhta1y8KaK $ANAC $ACTV $RPRX
Stock Rocket
4 Jul 15 19:44:52
Our Penny Stock Newsletter Alerts Gained 200% In 2 Weeks! Get Our Next Pick Early: http://t.co/4eX1MHBloV $ANAC $ACTV $RPRX
PHARMD
4 Jul 15 06:49:49
@dds_dave @pbmech my target to sell 70% before fda decision. fda could delay for approval for 2-3 mths since pdufa 2 wks after adcom $rprx
PHARMD
4 Jul 15 06:47:50
@dds_dave @pbmech have a small position bought at 7.4. definitely will buy big if offering before adcom. overall data very good. $rprx
Ponty
3 Jul 15 23:10:21
@Pharmdca @dds_dave if they don't offered B4 Adcom, huge sign of confidence, coz after they may not be able to raise anything. $RPRX
Ponty
3 Jul 15 23:07:20
RT @Pharmdca: @dds_dave @pbmech oral testosterone $rprx has no adverse effect on fertility as compared with other testosterone therapies
PHARMD
3 Jul 15 22:19:40
@dds_dave @pbmech oral testosterone $rprx has no adverse effect on fertility as compared with other testosterone therapies
Stocks Rocks
3 Jul 15 22:18:03
RT @dds_dave: @pbmech the MC is low for your liking but I think the data is very good on $RPRX. Upcoming ADCOM in November, so now is a goo…
Gotham City Capital
3 Jul 15 22:16:15
@Pharmdca @pbmech @dds_dave $38M cash.. tough call on hold with that low cash.. More likely than not post approval raise.. $RPRX
PHARMD
3 Jul 15 22:11:07
@pbmech @dds_dave Ponty why u think they will do offering before adcom? $rprx
PHARMD
3 Jul 15 22:09:41
@pbmech @dds_dave $rprx no cv risk factors compared to androgel. If approved this could go back to 30's easily
PHARMD
3 Jul 15 22:08:32
@pbmech @dds_dave $rprx way better in terms of safety compared to androgel. I bet this will trade over or around 12/15 around adcom
Ponty
3 Jul 15 21:52:53
RT @dds_dave: @pbmech big advantage $RPRX has is oral administration. Can't have application site issues,
dds_dave
3 Jul 15 19:55:34
@pbmech big advantage $RPRX has is oral administration. Can't have application site issues,
Ponty
3 Jul 15 19:40:17
RT @dds_dave: @pbmech the MC is low for your liking but I think the data is very good on $RPRX. Upcoming ADCOM in November, so now is a goo…
Gotham City Capital
3 Jul 15 19:25:58
@dds_dave @pbmech Good catch on $RPRX.. Another great PDUFA play for EOY.. W/ $BDSI $NKTR $RLYP $MACK
Ponty
3 Jul 15 19:23:36
RT @dds_dave: @pbmech I'll do some digging. From $RPRX own trial these were the ae's http://t.co/AUFEXAhPSV
dds_dave
3 Jul 15 19:21:57
@pbmech I'll do some digging. From $RPRX own trial these were the ae's http://t.co/AUFEXAhPSV
Ponty
3 Jul 15 18:57:14
Entering $RPRX (half pos now, half after offering maybe). Adcom shud approve, expecting mostly labeling discussion.
Ponty
3 Jul 15 18:26:53
@dds_dave looks like some controversy over Low-T drugs in general.FDA un-fav to life-style use. But what is $RPRX AdCom for specifically?
Ponty
3 Jul 15 11:04:53
@dds_dave thnx. I'll chk $RPRX. Looks like bottomed.
dds_dave
3 Jul 15 10:56:39
@pbmech the MC is low for your liking but I think the data is very good on $RPRX. Upcoming ADCOM in November, so now is a good time to buy
stockschamp
3 Jul 15 10:44:11
Premium Alerts Ranked #1 For Gains 2834% Last Week http://t.co/8WvnrVmkBS .. $ANAC $ACTV $RPRX
dds_dave
3 Jul 15 09:24:30
RT @DrSManian: $RPRX AdCom 11/3; should runup into midteens; +AdCom would be 30+
Penny Stock Secret
3 Jul 15 03:30:32
Gains Over 2500% In one Trade.. Subscribe Here! http://t.co/SVqoMkrw2z .. $ANAC $ACTV $RPRX
Michael Cook
2 Jul 15 23:37:28
Our Penny Stock Pick On $GEQU Closed Up 50% For Our Platinum Members Yesterday! Huge News: http://t.co/91VffBsuoJ $ANAC $ACTV $RPRX
Paul Henry
2 Jul 15 17:23:00
Our Penny Stock Picks Have Gained 3,600% In 9 Months! Subscribe To Get Our Future Picks: http://t.co/0VyTzPR97b $ANAC $ACTV $RPRX
Michael James
2 Jul 15 17:01:30
We have a MASSIVE New Penny Stock Pick, Coming This Week! Get It Early: http://t.co/NH4n77Y8Db $ANAC $ACTV $RPRX
HS Stock Trader
2 Jul 15 16:33:14
#ONCI $ONCI will run hard next week! $EXEL $PNQI $CLBH $LORL $SPLK $GRVY $NTRSP $RPRX $SKOR $KFX $CLWT $JBLU $CNET $PCYC $PTCT $AMBA
Penny Stockington
2 Jul 15 16:22:58
$SUTI Has Gained 66.67%, Since Our Penny Stock Blog Alert! Huge News: http://t.co/llIxl7uvGj $ANAC $ACTV $RPRX
Stockaholics
2 Jul 15 16:11:49
$SUTI Has Now Seen 400% Gains In The Past 2 Weeks! Special Update: http://t.co/l1zbyeF3OQ $ANAC $ACTV $RPRX
Stock Dawgzz
2 Jul 15 16:10:34
Our Platinum Subscribers Saw Their Penny Stock Alerts Gain Over 200% In 2 Weeks! Big Update: http://t.co/Lhta1yqlzk $ANAC $ACTV $RPRX
Stock Rocket
2 Jul 15 16:08:32
Our Penny Stock Newsletter Alerts Gained 200% In 2 Weeks! Get Our Next Pick Early: http://t.co/4eX1MHBloV $ANAC $ACTV $RPRX
Michael Cook
2 Jul 15 13:43:34
Our Penny Stock Pick On $GEQU Closed Up 50% For Our Platinum Members Yesterday! Huge News: http://t.co/91VffBaT09 $ANAC $ACTV $RPRX
Paul Henry
2 Jul 15 13:31:06
Our Penny Stock Picks Have Gained 3,600% In 9 Months! Subscribe To Get Our Future Picks: http://t.co/0VyTzPzxIB $ANAC $ACTV $RPRX
Penny Stockington
2 Jul 15 13:25:58
$SUTI Has Gained 66.67%, Since Our Penny Stock Blog Alert! Huge News: http://t.co/llIxl7uvGj $ANAC $ACTV $RPRX
Michael James
2 Jul 15 13:23:18
We have a MASSIVE New Penny Stock Pick, Coming This Week! Get It Early: http://t.co/NH4n77GxeB $ANAC $ACTV $RPRX
Paul Henry
2 Jul 15 10:14:46
Our Penny Stock Picks Have Gained 3,600% In 9 Months! Subscribe To Get Our Future Picks: http://t.co/0VyTzPR97b $ANAC $ACTV $RPRX
Michael James
2 Jul 15 10:00:44
We have a MASSIVE New Penny Stock Pick, Coming This Week! Get It Early: http://t.co/NH4n77GxeB $ANAC $ACTV $RPRX
Corabelle FELICA
2 Jul 15 09:23:22
Brean Capital reaffirmed their buy rating on shares of $RPRX in a report issued. They currently have a $41.00 target price on the stock.
Daily Contracts
2 Jul 15 08:10:04
Real-Time feed of company contracts, original agreements and executive updates from $RPRX http://t.co/pdlwyhJUXW
Mussocpa.net
2 Jul 15 07:40:47
$RPRX triple bottom formed http://t.co/ZQzHjxUEA0
K. Trox
2 Jul 15 07:14:35
Added $RPRX down here sub $7.30
K. Trox
2 Jul 15 07:14:06
$CFRX $VTL $BDSI $RPRX all near or in their buy zones IMO
				
				
By  +Follow September 17, 2013 8:01AM
Share:

Comments

 

blog comments powered by Disqus

 

 Today's Must Reads

Microsegmentation: The Future of Cybersecurity?


How this Playboy Playmate Became a Better Stock Trader Than You

Long Term Rates Are On The Up…What’s Next?

The Modern Web: So Many Ways to Invest in Wireless Mobile Stocks

It's Time for the Rest of the Country to Legalize Weed

 

Do you expect a 10% correction by the end of 2015? in Equities.com Polls on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN